openPR Logo
Press release

Pneumonia Vaccine Market Current Situation and Growth by Top Vendors- J&J, Pfizer, GSK, Merck, Serum Institute of India, AstraZeneca, Sanofi Pasteur | Forecast 2021-2025

04-02-2021 12:04 PM CET | Health & Medicine

Press release from: Business Industry Reports

Pneumonia Vaccine Market

Pneumonia Vaccine Market

Global Pneumonia Vaccine Market Synopsis:

The report covers a forecast and an analysis of the Pneumonia Vaccine Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Pneumonia Vaccine Market along with the impact they have on the demand over the forecast period.

According to the market research study, Pneumonia is disease that causes lung contamination occurring in one or both the lungs caused by bacterial organisms, viruses, or fungi; bacterial pneumonia is the most common in adults. As per the National Center for Immunization and Respiratory Diseases, each year in the United States, more than 250,000 people are hospitalized due to pneumonia and about 50,000 people die from the disease each year in the United States.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/275719 .

Some of the most significant key factors driving the growth of the Global Pneumonia Vaccine Market are rapid growth in the prevalence of pneumococcal diseases amongst the population and the introduction of novel vaccines, growing awareness programs about pneumococcal diseases initiated by the Government.

On the basis of Regional analysis, North America is expected to dominate the overall market, throughout the forecast period. Factors such as the presence of key players and established healthcare infrastructure are the key factors accountable for its large share in the market. APAC is the fastest-growing region due to the high prevalence of Pneumonia infection. The major countries of this region have the highest-burden in the world and hence there is more need for vaccination to prevent the disease.

This report contains a complete product overview and its scope in the market to define the key terms and provide the clients a holistic idea of the market and its tendency. It comprehensively evaluates the Global Pneumonia Vaccine Market with different perspectives for the purpose of providing a detailed, informative, and accurate analysis of regional growth, competition, market segmentation, and other important aspects.

Global Key Players:

1 Pfizer Inc

2 Glaxosmithkline Plc

3 Merck & Co., Inc

4 Sanofi Pasteur

5 Serum Institute of India Pvt. Ltd

6 Johnson & Johnson

7 Astellas Pharma Inc

8 Astrazeneca Plc

9 CSL Limited

10 Emergent Biosolutions and More………………

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Pneumonia Vaccine Market Report 2021” @ https://www.businessindustryreports.com/buy-now/275719/single .

Product Type Segmentation

1 Pneumococcal Conjugate Vaccine (PCV13)

2 Pneumococcal Polysaccharide Vaccine (PPSV23)

Industry Segmentation

1 Pneumonia

2 Meningitis

3 Sepsis

International Medical Industry News:

Serum Institute of India (February 15, 2021) - World Health Organisation (WHO) grants Emergency Use Listing (EUL) for the AstraZeneca/Oxford COVID-19 vaccine manufactured by Serum Institute of India - AstraZeneca’s COVID-19 vaccine has been granted Emergency Use Listing (EUL) by the World Health Organization (WHO) for active immunisation to prevent COVID-19 in individuals 18 years of age and older, including those over 65.

The authorisation of COVID-19 Vaccine AstraZeneca manufactured by AstraZeneca, and COVISHIELD manufactured by Serum Institute of India (SII), enables global access to the vaccine during the pandemic.

The EUL allows for two doses of the vaccine to be administered at a four to 12-week interval. This regimen was shown in clinical trials to be safe and effective in preventing symptomatic COVID-19, with no severe cases and no hospitalisations more than 14 days after the second dose. The WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) recommended a dosing interval of eight to 12 weeks. In addition, they also recommended use of the vaccine in countries where new variants, including the South African B1.351 variant, are prevalent.

AstraZeneca and SII will now work with the COVAX Facility to begin supplying the vaccine around the world, with the majority going to low and middle-income countries as quickly as possible. In the first half of 2021, it is hoped that more than 300 million doses of the vaccine will be made available to 145 countries through COVAX, pending supply and operational challenges. These doses will be allocated equitably according to the COVAX Allocation Framework.

Pascal Soriot, Chief Executive Officer, said: “Today’s approval endorses that the vaccine can be used to help protect populations across the world, including adults over 65 years and in countries where different variants of the SARS-CoV-2 virus are in circulation. This is a huge step towards ensuring global access to our vaccine and helping us fulfil our public health commitment to broad and equitable access at no profit during the pandemic.”

Adar Poonawalla, Chief Executive Officer, Serum Institute of India, said: “We have been waiting for this final milestone. I am happy and relieved that with the WHO's EUL we will be able to start the deliveries to African and other low and middle-income countries immediately. Countries with a large population must be protected as soon as possible.”

AstraZeneca has committed to making its COVID-19 vaccine available to as many countries as possible and at no profit during the pandemic period. In June 2020, the Company announced a sub-licencing agreement with the SII to manufacture and supply up to one billion doses of the vaccine to low and middle-income countries.

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/275719 .

Major Points in Table of Contents:

Global Pneumonia Vaccine Market Report 2021

1 Pneumonia Vaccine Product Definition

2 Global Pneumonia Vaccine Market Manufacturer Share and Market Overview

2.1 Global Manufacturer Pneumonia Vaccine Shipments

2.2 Global Manufacturer Pneumonia Vaccine Business Revenue

2.3 Global Pneumonia Vaccine Market Overview

3 Manufacturer Pneumonia Vaccine Business Introduction

3.1 Pfizer Inc. Pneumonia Vaccine Business Introduction

3.2 Glaxosmithkline Plc. Pneumonia Vaccine Business Introduction

3.3 Merck & Co., Inc. Pneumonia Vaccine Business Introduction

3.4 Sanofi Pasteur Pneumonia Vaccine Business Introduction

3.5 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Business Introduction

3.6 Johnson & Johnson Pneumonia Vaccine Business Introduction

About us

BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that hold the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic, and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pneumonia Vaccine Market Current Situation and Growth by Top Vendors- J&J, Pfizer, GSK, Merck, Serum Institute of India, AstraZeneca, Sanofi Pasteur | Forecast 2021-2025 here

News-ID: 2265370 • Views: 469

More Releases from Business Industry Reports

Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo …
BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Tetracaine Market” Research Report 2021 provides an in-depth analysis of the Tetracaine with the forecast of market size and growth. The analysis includes addressable market, market by volume, market share by business type and by segment (external and in-house). The research study examines the Tetracaine on the basis of a number of criteria,
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size …
Overview of Global Cyber Warfare Market: This report provides in-depth study of “Global Cyber Warfare Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cyber Warfare Market report also provides an in-depth survey of key players in the market organization. According to the market research study, the Cyber Warfare is virtual conflict between state, organization, or country by the use of computer technology to disrupt activities
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growt …
Overview of Global Cranio Maxillofacial Implant Market: This report provides in-depth study of “Global Cranio Maxillofacial Implant Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cranio Maxillofacial Implant Market report also provides an in-depth survey of key players in the market organization. According to the market research study, Craniomaxillofacial Implants are medical implants used in surgeries of maxillofacial region such as, head, face, neck, oral,
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key …
Global Biohacking Market Synopsis: The report covers a forecast and an analysis of the Biohacking Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Biohacking Market along with the impact they have on the demand over the forecast

All 5 Releases


More Releases for Pneumonia

Global Pneumonia Therapeutics Market 2018 – 2023
Global Pneumonia Therapeutics Market 2018–2023 Poised for xx% Growth Planet Market Research has recently added a market study named Global Pneumonia Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023 with prime importance on the forecast period from 2018 to 2023. The report is an in-depth analysis of the market for pneumonia therapeutics and covers various driving factors, restraints, opportunities and challenges affecting the market’s growth. Pneumonia is an
Pneumonia Drug Development Market Focuses on Top Players (Hospital Acquired Pneu …
Pneumonia Drug Development Market study provides comprehensive data which enhances the understanding, scope and application of this report. Polyamides, polyethylene, nylons, epoxy resins, polysulfones, polyphthalamides, polyesters, and polycarbonates are some key forms of plastics that are employed in electronic components. The insulation properties of plastic account for its in depth use in electrical and electronic components of machines and gadgets. Report Consultant has introduced a new report titled as Global Pneumonia
Pneumonia Testing Market Opportunity Analysis, 2018-2026
Pneumonia is a lung infection caused by bacteria, viruses or fungi, primarily affecting the small sir sacs known as alveoli. The most common bacterial type that causes pneumonia is Streptococcus pneumoniae. The symptoms for pneumonia include, fever, chills, cough, shortness of breath and fatigue. To detect whether, a person has pneumonia are blood tests, chest X-ray, pulse oximetry, and Sputum test. Further, if the patients is older than age 65,
Pneumonia Diagnostics Market worth US$ 685 Mn by 2027
The World Health Organization estimates that pneumonia accounted for 16% of all deaths of children below the age of 5 years – more than 920,000 in 2015. The WHO states that the cost of pneumonia antibiotic treatment in the same year for child survival and newly born babies is roughly US$ 110 million annually. Therefore, there is a pressing need to analyse the pneumonia diagnostics market. In an upcoming report
Pneumonia Drug Development Pipeline Review, 2017
This report provides an overview of the pipeline landscape for pneumonia disorders. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Community Acquired Pneumonia, Hospital Acquired Pneumonia and Ventilator Associated Pneumonia and features dormant and discontinued projects. Summary Community acquired pneumonia is pneumonia contracted by a person who has had little contact with the healthcare system, with common symptoms including cough, fever and
Pneumonia Vaccine Market- GlaxoSmithKline, Pfizer, Merck
Global Pneumonia Vaccine Market Size, Status and Forecast 2022 provides Market information about Manufacturers, Countries, Type and Application.This Industry report also states Company Profile, sales, Pneumonia Vaccine Market revenue and price, market share, market growth and gross margin by regions. Top Manufacturers/Key Players:- GlaxoSmithKline Pfizer Merck Enquiry for buying report @ https://goo.gl/793aS1 The Global Pneumonia Vaccine report gives a thorough situation of the present and gauge Pneumonia Vaccine showcase procedures, improvement methodologies and development openings.